Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.20.2
Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Operating Expenses:        
Research and development $ 12 $ 154 $ 336 $ 988
Selling, general and administrative expenses 1,546 2,125 2,292 5,347
Total operating expenses 1,558 2,279 2,628 6,335
Loss from operations (1,558) (2,279) (2,628) (6,335)
Other Income (Expense):        
Loss on disposal of assets 0 (31) 0 (31)
Settlement expense (2,563) 0 (2,563) 0
Interest expense (4,658) (479) (5,296) (933)
Total other income (expense) (7,221) (510) (7,859) (964)
Loss before provision for income taxes (8,779) (2,789) (10,487) (7,299)
Provision for income taxes 0 0 0 0
Net loss $ (8,779) $ (2,789) $ (10,487) $ (7,299)
Net loss per common share - basic and diluted $ (.12) $ (.05) $ (.15) $ (0.14)
Weighted average common shares outstanding - basic and diluted 71,899,937 51,918,252 70,978,579 51,507,849